Opportunity Information: Apply for PAR 23 174
The Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) is an NIH grant opportunity from the National Institute on Aging (NIA) designed to support doctoral dissertation research focused on aging and aging-related health conditions. Its central goal is to expand and strengthen diversity in the scientific workforce by providing targeted dissertation-stage funding to researchers working in areas that align with NIA strategic priorities. In practice, the award is meant to help eligible doctoral candidates move their dissertation projects forward and build a stronger pathway into an aging research career, while also encouraging broader participation from individuals and institutions that have been historically underrepresented in biomedical, behavioral, clinical, and social science research.
This opportunity uses the NIH R36 mechanism, which is specifically structured as a dissertation award. The NOFO explicitly states that clinical trials are not allowed under this funding announcement, meaning applicants must propose research that does not meet NIH’s definition of a clinical trial. Projects can still be human-subjects research if otherwise appropriate, but they cannot involve prospective assignment to an intervention with the intent to evaluate effects on health-related outcomes. The scientific scope is broad as long as it fits within NIA’s mission and strategic research priorities related to aging, including the study of aging processes, age-related disease and conditions, health disparities in older populations, caregiving, dementia and Alzheimer’s-related research, social and behavioral aspects of aging, and other aging-relevant topics that NIA supports.
Eligibility spans a wide range of U.S.-based organizations and public or private entities. The listed eligible applicant types include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (when not functioning as institutions of higher education); for-profit organizations other than small businesses; and small businesses, as well as other organizations that may meet NIH eligibility rules. The announcement also calls out additional eligible groups and institution types that are often central to diversity-focused initiatives, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also notes that faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions may be eligible applicants.
At the same time, the NOFO includes clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. It also states that non-domestic components of U.S. organizations are not eligible, and that foreign components as defined in the NIH Grants Policy Statement are not allowed. In other words, applications must be fully anchored in eligible U.S. entities without foreign components.
Administratively, the opportunity is categorized as a discretionary grant under the health funding activity category, tied to CFDA number 93.866. The funding opportunity number is PAR-23-174, and the sponsoring agency is the National Institutes of Health. The original closing date listed for this specific posting is 2023-11-16, with a creation date of 2023-05-11. The source data provided does not specify an award ceiling or the expected number of awards, so those details are not available from the text you shared.
Overall, this NOFO is best understood as dissertation-stage support for aging research that also serves a workforce development purpose: helping diversify who is doing aging research and what perspectives are represented in the science of aging, while keeping the supported projects within NIA priorities and outside the scope of NIH-defined clinical trials.Apply for PAR 23 174
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2023-05-11.
- Applicants must submit their applications by 2023-11-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
What is the Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)?
This is an NIH grant opportunity from the National Institute on Aging (NIA) that supports doctoral dissertation research focused on aging and aging-related health conditions. The award is intended to help eligible doctoral candidates move their dissertation projects forward while also strengthening diversity in the scientific workforce aligned with NIA strategic priorities.
What is the main purpose of this award?
The central goal is to expand and strengthen diversity in the scientific workforce by providing dissertation-stage funding to researchers working on topics that align with NIA strategic priorities in aging research. It is positioned as both research support and a pathway-building opportunity toward an aging research career.
Which NIH institute sponsors this opportunity?
The sponsoring institute is the National Institute on Aging (NIA), which is part of the National Institutes of Health (NIH).
What grant mechanism does this funding opportunity use?
This opportunity uses the NIH R36 mechanism, which is specifically structured as a dissertation award mechanism.
Are clinical trials allowed under this funding announcement?
No. The NOFO explicitly states that clinical trials are not allowed (R36 Clinical Trial Not Allowed). Proposed projects must not meet NIH's definition of a clinical trial.
What does "clinical trial not allowed" mean in practical terms?
Applicants cannot propose research that involves prospective assignment to an intervention with the intent to evaluate the effect of that intervention on health-related outcomes. Human-subjects research may still be allowable if it does not meet NIH's clinical trial definition.
Can I propose human subjects research if it is not a clinical trial?
Yes. The description indicates projects can involve human-subjects research if otherwise appropriate, as long as the work does not meet NIH's definition of a clinical trial.
What types of research topics are within scope for this award?
The scientific scope is broad as long as it fits within NIA's mission and strategic research priorities related to aging. Examples mentioned include aging processes, age-related diseases and conditions, health disparities in older populations, caregiving, dementia and Alzheimer's-related research, and social and behavioral aspects of aging, along with other aging-relevant topics supported by NIA.
Does the award focus only on biomedical research?
No. The NOFO references a wide range of fields, including biomedical, behavioral, clinical (non-trial), and social science research, as long as the project aligns with NIA priorities and stays outside NIH-defined clinical trials.
Who is this award intended to support?
It is designed to support doctoral dissertation research and is described as dissertation-stage funding intended to help eligible doctoral candidates advance their dissertation projects and strengthen their pathway into an aging research career.
What kinds of organizations are eligible to apply?
Eligibility spans a wide range of U.S.-based organizations and public or private entities. Examples listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (when not functioning as institutions of higher education); for-profit organizations other than small businesses; and small businesses, as well as other organizations that may meet NIH eligibility rules.
Are certain institution types specifically highlighted as eligible?
Yes. The announcement specifically calls out institution types often associated with diversity-focused initiatives, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are faith-based or community-based organizations eligible to apply?
The description notes that faith-based or community-based organizations may be eligible applicants, consistent with NIH eligibility rules.
Are U.S. territories or possessions eligible?
Yes. The opportunity notes that U.S. territories or possessions may be eligible applicants.
Are federal agencies eligible applicants?
The description indicates that eligible federal agencies may be eligible applicants.
Can a non-U.S. (foreign) institution apply?
No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.
Can a U.S. organization apply if it has a non-domestic component?
No. The NOFO states that non-domestic components of U.S. organizations are not eligible.
Are foreign components allowed in the proposed project?
No. The NOFO states that foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
What does the NOFO require regarding foreign involvement overall?
The description emphasizes that applications must be fully anchored in eligible U.S. entities and cannot include foreign institutions, non-domestic components, or foreign components as defined by NIH policy.
What is the funding opportunity number (NOFO number)?
The funding opportunity number is PAR-23-174.
What is the CFDA number listed for this opportunity?
The opportunity is tied to CFDA number 93.866.
How is this opportunity categorized administratively?
It is categorized as a discretionary grant under the health funding activity category.
What is the closing date listed for this posting?
The original closing date listed for this specific posting is 2023-11-16.
What is the creation date listed for this posting?
The creation date listed is 2023-05-11.
Is the award ceiling (maximum award amount) provided in the information shared?
No. The source information provided does not specify an award ceiling.
Is the expected number of awards provided?
No. The source information provided does not specify the expected number of awards.
How does this award relate to workforce diversity?
The NOFO describes diversity as a central goal: the award aims to broaden participation from individuals and institutions historically underrepresented in biomedical, behavioral, clinical, and social science research, while supporting dissertation-stage progress in NIA-aligned aging research.
What is the overall takeaway on what this NOFO supports?
In plain terms, this is dissertation-stage support for aging research that aligns with NIA priorities, is intended to help diversify the aging research workforce, and must remain outside the scope of NIH-defined clinical trials.
Browse more opportunities from the same category: Health
Next opportunity: IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)
Previous opportunity: Fiscal Year 2023 Individual State Earthquake Assistance (ISEA) - Region 10
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 174
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 174) also looked into and applied for these:
| Funding Opportunity |
|---|
| Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) Apply for PAR 23 177 Funding Number: PAR 23 177 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| HIV Prevention and Alcohol (R01 Clinical Trials Optional) Apply for PAS 23 173 Funding Number: PAS 23 173 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Prevention and Alcohol (R34 Clinical Trials Optional) Apply for PAS 23 172 Funding Number: PAS 23 172 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PAR 23 185 Funding Number: PAR 23 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 23 186 Funding Number: PAR 23 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) Apply for PAR 23 187 Funding Number: PAR 23 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed) Apply for RFA NS 24 010 Funding Number: RFA NS 24 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Treatment and Recovery Research (R34 Clinical Trial required) Apply for PAR 23 188 Funding Number: PAR 23 188 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 029 Funding Number: RFA AI 23 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional) Apply for RFA NS 23 027 Funding Number: RFA NS 23 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 021 Funding Number: RFA AG 24 021 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed) Apply for RFA AI 23 032 Funding Number: RFA AI 23 032 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 023 Funding Number: RFA AG 24 023 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 022 Funding Number: RFA AG 24 022 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)? Apply for RFA AG 24 038 Funding Number: RFA AG 24 038 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)? Apply for RFA AG 24 036 Funding Number: RFA AG 24 036 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Health Information Systems (HIS) Activity Apply for 72052123RFI00001 Funding Number: 72052123RFI00001 Agency: Haiti USAID-Port Au Prince Category: Health Funding Amount: Case Dependent |
| Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed) Apply for RFA NS 24 003 Funding Number: RFA NS 24 003 Agency: National Institutes of Health Category: Health Funding Amount: $1,300,000 |
| Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed) Apply for PAR 23 211 Funding Number: PAR 23 211 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) Apply for PAR 23 212 Funding Number: PAR 23 212 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 174", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.